Halbert Hargrove Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
41
2025
Q4
Hold
0
36
2025
Q3
Hold
0
45
2025
Q2
Hold
0
41
2025
Q1
Hold
0
36
2024
Q4
Hold
0
40
2024
Q3
Hold
0
-$1.54M 97
2024
Q2
Hold
0
35
2024
Q1
Hold
0
38
2023
Q4
Hold
0
43
2023
Q3
Hold
0
41
2023
Q2
Hold
0
40
2023
Q1
Hold
0
62
2022
Q4
Hold
0
57
2022
Q3
Hold
0
61
2022
Q2
Hold
0
63

Other funds holding LLY

Halbert Hargrove Global Advisors's LLY Position: Q1 2026 in Review

Halbert Hargrove Global Advisors reduced its Eli Lilly (LLY) stake by 3% in Q1 2026, selling an estimated $54.7K and leaving 1,746 shares worth $1.61M. The position accounts for 0.08% of the portfolio, ranked #40.

Halbert Hargrove Global Advisors first reported a position in LLY in Q1 2015 and has held it in 28 quarters since. The position peaked at $1.94M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Halbert Hargrove Global Advisors held 1,746 shares of Eli Lilly worth $1.61M as of Q1 2026.
  • Halbert Hargrove Global Advisors sold 54 Eli Lilly shares in Q1 2026, an estimated $54.7K.
  • Eli Lilly made up 0.08% of Halbert Hargrove Global Advisors's portfolio in Q1 2026, its #40 holding.
  • Halbert Hargrove Global Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 28 quarters since.
  • Halbert Hargrove Global Advisors's Eli Lilly position peaked at $1.94M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.